PSY180 - UK HEALTH TECHNOLOGY ASSESSMENT OF ORPHAN DRUGS FOR RARE ONCOLOGY VERSUS RARE DISEASE: DOES ORPHAN DESIGNATION MAKE ANY DIFFERENCE IN HTA PROCESS?S. KellyVALUE IN HEALTH（2018）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
